Oct 2026· The Laryngoscope· 0 citations· 34 references
Medicine
TL;DR
Pretreatment HRQoL provides multidimensional prognostic information, with Global QoL and physical, role, emotional, and social functioning showing the most consistent evidence, and these domains may help prioritize pretreatment supportive-care assessment.
Abstract
Objective
To quantify associations between pretreatment patient-reported health-related quality of life (HRQoL) domains and overall survival in head and neck cancer.
DATA SOURCES
PubMed, Embase, and Web of Science were searched from inception through July 27, 2026.
REVIEW
Methods
Longitudinal studies evaluating validated patient-reported HRQoL as a prognostic exposure were included. Adjusted hazard ratios (HRs) for overall survival were harmonized to a 10-point worsening and pooled by domain using restricted maximum-likelihood random-effects models. Risk of bias, multiplicity, leave-one-out stability, cohort overlap, residual-confounding sensitivity, and reporting completeness were evaluated.
Results
Thirty-two independent studies in 40 publications were included; 43 estimates contributed to meta-analyses of 10 domains. Worse Global QoL (HR, 1.11; 95% CI, 1.08-1.14), physical functioning (1.16; 1.13-1.20), role functioning (1.09; 1.07-1.11), and social functioning (1.09; 1.06-1.12) were consistently associated with higher mortality and remained leave-one-out stable. Swallowing was associated with mortality (1.15; 1.02-1.29) but was sensitive to one study. Dyspnea was associated with higher mortality in the primary analysis (4 studies; HR, 1.16; 95% CI, 1.01-1.33), but the estimate was heterogeneous and unstable.
Conclusion
Pretreatment HRQoL provides multidimensional prognostic information, with Global QoL and physical, role, emotional, and social functioning showing the most consistent evidence. These domains may help prioritize pretreatment supportive-care assessment, whereas sensitivity-limited or very-low-certainty findings require further confirmation and should not be interpreted as actionable treatment targets.
LEVEL OF EVIDENCE
N/A.
TRIAL REGISTRATION
PROSPERO number: CRD420261461389.
BACKGROUND
It is unclear whether glioma subtypes differ in health-related quality of life (HRQoL) over time.
METHODS
We analyzed data from the CODAGLIO 2.0 database, comprising 16 randomized controlled trials with HRQoL assessed using the EORTC QLQ-C30 and QLQ-BN20 questionnaires. Differences in mean HRQoL at baselin...
O. A. Asogwa, L. Dirven, M. J. van den Bent et al.· Neuro-Oncology· 0 citations
Background Physical functioning has emerged as a potentially valuable prognostic indicator in patients with nonsmall cell lung cancer (NSCLC). This systematic review and meta-analysis aimed to evaluate the prognostic value of objectively measured components of physical functioning on survival outcomes across treatment...
E. Arents, S. Haesevoets, Marthe Van Overbeke et al.· European Respiratory Review· 0 citations
Higher symptom burden was consistently associated with poorer quality of life, especially in physical functioning, pain, and disease-specific concerns, in this multicenter cohort of patients with multiple myeloma.
J. Alkrinawi, Nizar Abu Hamdeh, M. Alnees et al.· Oncology· 0 citations
Globally, Black men suffer the greatest prostate cancer (CaP) burden. This study evaluated health-related quality of life (HRQOL) among Black prostate cancer survivors (CaPS) and compared their HRQOL by stage. We used a validation study to compare the HRQOL outcomes between the validation study and our sample....
K. Ashing, Floyd Willis, Christopher Williams et al.· Cancer Epidemiology, Biomark...· 0 citations
OBJECTIVE
To investigate the prognostic impact of preoperative self-reported global health status, assessed with the EQ-5D visual analogue scale (VAS), on recurrence-free survival (RFS) in patients undergoing resection for clinical stage I non-small cell lung cancer (NSCLC).
METHODS
This retrospective study included...
H. Ichimura, Keisuke Kobayashi, Masahiko Gosho et al.· Interdisciplinary cardiovasc...· 0 citations
Cancer-related fatigue (CRF) remains one of the most common and persistent complications among breast cancer survivors, profoundly impairing their psychosocial well-being. Although various predictors have been proposed, existing evidence yields inconsistent findings. This study aimed to systematically synthesize mu...
Bai-Ru Ba, Xiao-Feng Wang, Hong Ye et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.